Search results for "Heart failure"


 
Results 121 - 130 of about 415 for "Heart failure".
Sort by: Relevance | Newest | Oldest

Diagnosis at 10 paces for bitemporal wasting

In a new series, Pearls from I.M. Peers, Paul Dallas, MD, MACP, explains how making a simple observation in a patient could indicate a serious diagnosis.
https://acpinternist.org/archives/2022/01/diagnosis-at-10-paces-for-bitemporal-wasting.htm
1 Jan 2022

Beta-blockers not associated with lower risk of death after acute MI in patients without heart failure, study finds

The insignificant effect of beta-blockers on survival was also apparent at one month and six months after discharge, as well as in separate analyses of patients with STEMI and NSTEMI.
https://acpinternist.org/weekly/archives/2017/06/06/5.htm
6 Jun 2017

Details on COVID-19 treatments authorized for outpatients

This column reviews details on recent recalls, alerts, and approvals.
https://acpinternist.org/archives/2022/03/details-on-covid-19-treatments-authorized-for-outpatients.htm
1 Mar 2022

Effects of heart failure therapies on quality of life compared

Sacubitril/valsartan may improve limitations in physical and social activities that are important to patients with heart failure, researchers noted.
https://acpinternist.org/weekly/archives/2018/04/10/1.htm
10 Apr 2018

Ischemic heart disease linked to worse prognosis in heart failure patients with type 2 diabetes

Type 2 diabetes was associated with greater risk for all-cause mortality in patients with ischemic and nonischemic heart failure, previous revascularization was associated with better survival, and most patients with type 2 diabetes and nonischemic heart failure had at least 1 treatable comorbid condition associated with heart failure risk.
https://acpinternist.org/weekly/archives/2016/09/20/4.htm
20 Sep 2016

Sacubitril-valsartan appears cost-effective in certain heart failure patients

Treatment value was highest in patients with class II heart failure, who also benefited most from treatment in the PARADIGM-HF trial, and improved outcomes with the drug would need to be sustained for at least 36 months to keep the cost per quality-adjusted life-year below a $100,000 threshold.
https://acpinternist.org/weekly/archives/2016/08/30/2.htm
30 Aug 2016

CA-125-guided therapy may improve outcomes for acute heart failure vs. standard of care

A multicenter randomized trial compared postdischarge therapy in patients who were hospitalized for acute heart failure and had high CA-125 levels.
https://acpinternist.org/weekly/archives/2016/08/16/4.htm
16 Aug 2016

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights of College offerings featured in our e-newsletter, ACP Internist Weekly.
https://acpinternist.org/archives/2018/09/latest-updates-on-acps-priorities-initiatives.htm
1 Sep 2018

MKSAP Quiz: 1-year history of edema, abdominal distention

A 72-year-old man is evaluated for a 1-year history of bilateral lower extremity edema and abdominal distention. Eight years ago he had esophageal carcinoma treated with radiotherapy. Medical history is otherwise significant for hypertension, type 2 diabetes mellitus, and hypercholesterolemia. Following a physical exam, lab studies, and chest radiographs, what is the most likely diagnosis?
https://acpinternist.org/archives/2020/02/mksap-quiz-1-year-history-of-edema-abdominal-distention.htm
1 Feb 2020

Closing care gaps in adult congenital heart disease

Many patients who are congenital heart disease survivors face gaps as they transition out of pediatric care, leading to problems that might have been avoided had they received appropriate, continuous care.
https://acpinternist.org/archives/2020/03/closing-care-gaps-in-adult-congenital-heart-disease.htm
1 Mar 2020

Result Page: Prev   8   9   10   11   12   13   14   15   16   17   Next